Archive - March 2021
Merck KGaA gains exclusive rights to Debiopharma’s late-stage oncology asset
MSD withdraws Keytruda’s US indication for small cell lung cancer
AZ sells stake in Moderna for around $1.2bn
Cosentyx gains EU approval for new label extension
NHS prescription charges set to rise in England
NICE backs selective internal radiation therapy for advanced liver cancer
Cancer Research UK teams up with Teon on new cancer drug
Roche, Genentech partner with The Weill Neurohub on ten-year neuroscience collaboration